|
1321 |
Spatially Resolved Electroluminescence of InGaN-MQW-LEDs
Enthalten in Materials Research Society: MRS online proceedings library Bd. 595, 3.9.2012, Nr. 1, date:12.1999: 1-5
|
|
|
|
1322 |
Spinal cord gray matter atrophy is associated with disability in spinal muscular atrophy
Enthalten in Journal of neurology Bd. 272, 7.1.2025, Nr. 1, date:1.2025: 1-12
|
|
|
|
1323 |
Stem quality assessment in European National Forest Inventories: an opportunity for harmonised reporting?
Enthalten in Annals of forest science Bd. 73, 31.7.2015, Nr. 3, date:9.2016: 635-648
|
|
|
|
1324 |
Stiff matrix induces switch to pure β-cardiac myosin heavy chain expression in human ESC-derived cardiomyocytes
Enthalten in Basic research in cardiology Bd. 111, 14.10.2016, Nr. 6, date:11.2016: 1-16
|
|
|
|
1325 |
Storage ring at HIE-ISOLDE
Enthalten in European physical journal special topics Bd. 207, 11.5.2012, Nr. 1, date:5.2012: 1-117
|
|
|
|
1326 |
Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension
Enthalten in Arthritis Research & Therapy Bd. 17, 19.6.2015, Nr. 1, date:12.2015: 1-11
|
|
|
|
1327 |
Study protocol for the implementation and evaluation of a digital-robotic-based intervention for nurses and patients in a hospital: a quantitative and qualitative triangulation based on the Medical Research Council (MRC) framework for developing and evaluating complex interventions
Enthalten in BMC nursing Bd. 21, 9.12.2022, Nr. 1, date:12.2022: 1-9
|
|
|
|
1328 |
Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer
Enthalten in BMC cancer Bd. 22, 27.7.2022, Nr. 1, date:12.2022: 1-14
|
|
|
|
1329 |
Success and safety of deep sedation as a primary anaesthetic approach for transvenous lead extraction: a retrospective analysis
Enthalten in Scientific reports Bd. 13, 27.12.2023, Nr. 1, date:12.2023: 1-7
|
|
|
|
1330 |
Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program
Enthalten in BMC cancer Bd. 16, 31.8.2016, Nr. 1, date:12.2016: 1-13
|
|
Administration
